Good glucose control [1, 2] and the treatment of hypertension [3] and hyperlipidaemia remain the key strategies in preventing diabetic retinopathy and its progression. Unfortunately, some degree of retinopathy will eventually develop in almost all type 1 diabetics and over 60% of type 2 diabetics over a 20-year period. [4] Diabetic retinopathy is usually asymptomatic in its early stages. Patients presenting with symptoms o en have more advanced disease and are more di cult to manage. ey are at higher risk of permanent visual loss. Screening is a cost-e ective tool in the ght against diabetic blindness. It involves assessment of visual acuity (including the use of a pinhole to overcome refractive error) and a retinal examination (fundoscopy) through a dilated pupil.
With the rising prevalence of diabetes there is an increasing need for e ective retinal screening. Fundus photography has established itself in many countries as the preferred tool for screening for diabetic retinopathy. Unfortunately fundus cameras are expensive and not yet widely available. While such screening programmes are being developed in the private and public sectors in South Africa, screening with a direct ophthalmoscope still has an important place in the detection of diabetic retinopathy. is article aims to review important clinical features of diabetic retinopathy and provide some practical tools for improved screening with the direct ophthalmoscope.
When to start screening
• Screening in children and adolescents:
annual screening to start 3 -5 years a er diagnosis, and once the patient is 10 years old. [5] • Type 1 diabetics generally do not develop retinopathy within 5 years of the diagnosis.
• Type 2 diabetics may have retinopathy before diabetes is diagnosed. ey should be screened at the time of diagnosis.
How often to screen
• Annual screening is recommended.
• Pregnant diabetics should preferably be screened before pregnancy, early in the rst trimester, in each trimester as well as 6 weeks postpartum. [6] 
Screening steps
Step 1: Visual acuity Visual acuity should be performed with the patient's current spectacles. A pinhole test is used if vision is below normal (6/6) . If the vision improves with the pinhole this suggests a residual refractive error. e importance of the visual acuity test is that maculopathy can be di cult to diagnose in some patients. Unexplained visual acuity of 6/12 or worse may indicate maculopathy even if not obvious on examination and should be referred.
Step 2: Dilate the pupils
Is it always safe to dilate the pupils? Short-acting dilating drops are extremely unlikely to cause ocular complications. [7] We would recommend Mydriacyl® (tropicamide) which lasts up 6 hours. One drop is instilled 3 or 4 times in each eye at 5-minute intervals.
e risk of precipitating acute glaucoma is extremely low, even in patients in whom the anterior chamber may look shallow. Patients with chronic glaucoma are also unlikely to experience adverse events from dilation. We consider it better to advise the patient about seeking care in the unlikely event of a complication rather than omitting to screen. An informed patient in this setting is better o than a predisposed patient who spontaneously develops acute glaucoma one evening as the pupil dilates physiologically.
Step 3: Examine the 'red reflex' is is done by examining the red re ection of light emerging from the eye with the ophthalmoscope held about 50 cm from the patient. Both eyes should be examined and compared.
Interpretation of abnormal red re ex: • Discrete small black areas: media opacities -most likely early cataract, sometimes corneal in origin.
• Di usely dull or no re ex: severe media opacity or disrupted anatomypossible vitreous haemorrhage or retinal detachment. ese will be accompanied by severe visual loss. Visualisation of the fundus may not be possible.
Step 4: Fundus examination
Pearls for the use of the direct ophthalmoscope:
• Examine the patient's right eye with your right eye, and le eye with your le eye. e index nger should be on the focus wheel at all times. If you are examining Advice to patients at the time of dilating:
• Complications are extremely unlikely.
• Symptoms of a possible complication:
painful, red eye with worsening rather than improving vision.
• Supply a contact number and course of action in the event of a suspected complication.
• Patients should not drive or engage in hazardous activities until vision clears as the pupils return to normal. Peripheral areas between vessels Microaneurysms Haemorrhages: 'dot' and 'blot' (Fig. 6 ) Larger 'blot' haemorrhages are a feature of more severe retinopathy, particularly if they occur in all four quadrants of the retina Exudates (yellow, discrete deposits or large clumps) Cotton wool spots (pale with blurred edges - Fig. 5 ) New vessels (NVE) Macula Exudates Haemorrhages Cotton wool spots: Any pathology in the macula is signi cant and should be referred. Pathology within 1 disc diameter of the centre of the fovea is particularly signi cant (Fig. 3b ) Fig. 1 . Normal fundus.
Fig. 2. Systematic examination.

How big is a 'blot' haemorrhage?
It is useful to compare the size of the haemorrhage with the diameter of the large veins that emerge from the optic disc. If a haemorrhage is at least as large as the vein diameter at the disc it is a 'blot' rather than a smaller 'dot' haemorrhage. 'Dot' haemorrhages and microaneurysms may be indistinguishable.
Tips for examining the macula (Fig. 3):
• Dim the ophthalmoscope light slightly • Start at the optic disc move temporally into the macula • To assess the fovea, ask the patient to look directly at the ophthalmoscope light • To identify small haemorrhages it can be helpful to use the 'red free' lter on the ophthalmoscope. is gives the light a green appearance and any haemorrhage will appear black. It will not improve visualising exudates which are best seen with the white light. • Be proactive about the retinal examination. Ask the patient to look in di erent directions. When the patient looks up, drop your head and look upwards to view the superior peripheral retina etc. Fig. 1 shows a normal fundus. Assessment of the fundus should be systematic (Fig. 2 ). One should grade the level of retinopathy and look for maculopathy separately.
e optic disc is a good starting point and serves as a reference location. Look particularly for the features listed in Table 1 at each location.
e ow diagram will help to identify the degree of retinopathy present and indicates when referral is necessary.
How urgently should patients be referred to an ophthalmologist?
Proliferative diabetic retinopathy should be seen within 1 -2 weeks. Moderate to severe non-proliferative retinopathy or maculopathy should be seen within 1 -2 months.
Treatment by the ophthalmologist
Laser treatment has been the cornerstone of treatment for diabetic retinopathy. is remains the case for proliferative retinopathy. Anti-vascular endothelial growth factor (anti-VEGF) agents and some steroid preparations are new and e ective treatments for some cases of macular oedema.
White scar tissue
New vessels grow on a sca old of tissue which eventually thickens to form tight scars. ese contract and cause a tractional retinal detachment. ese patients have proliferative diabetic retinopathy (Fig. 9) .
Fig. 9.
Scar tissue in proliferative diabetic retinopathy.
Haemorrhages in front of the retina:
• Haemorrhages lying on the surface of the retina obscure the retinal blood vessels.
• Haemorrhage into the vitreous obscures the retina completely. ese haemorrhages arise from new vessels and should be graded as proliferative diabetic retinopathy (Fig. 8) . 
Signs of previous treatment
Some patients have had laser treatment of their retinopathy (Fig. 10) . Predominantly black scarring occurs. If the patient has been referred to you by an ophthalmologist as stable following treatment, then annual fundoscopy is indicated. If there is uncertainty about the stability of the retinopathy the patient should be referred. 
In a nutshell
• Appropriate screening and referral for diabetic retinopathy will prevent blindness.
• Screening involves visual acuity, pupil dilation and fundus examination. • e degree of retinopathy and maculopathy should be assessed independently.
• Patients with mild non-proliferative retinopathy and no maculopathy should be screened annually.
• Refer diabetic patients with any of the following:
• visual acuity 6/12 or worse of uncertain cause (suspected maculopathy) • diabetic maculopathy • moderate diabetic retinopathy or worse.
